Clinical Trials in Almaty, Kazakhstan
8 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 2
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Inflammatory Bowel DiseasesCrohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)385 enrolled159 locationsNCT06226883
Recruiting
iCaReMe Global Registry
Heart FailureHypertensionChronic Kidney Disease+1 more
AstraZeneca35,000 enrolled55 locationsNCT03549754
Recruiting
Not Applicable
Expanding Medication-Assisted Therapies in Central Asia
Opioid-use Disorder
Yale University900 enrolled4 locationsNCT05579470
Recruiting
Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
Chronic Kidney DiseasesType 2 DiabetesObesity (Disorder)+2 more
Asfendiyarov Kazakh National Medical University6,720 enrolled1 locationNCT06953180
Recruiting
Clinical Efficacy of Ustekinumab in Crohn's Disease
Crohn's Disease
Kazakhstan Scientific Society for Study of intestine diseases150 enrolled4 locationsNCT06523647
Recruiting
Prospective Urban Rural Epidemiology Study
CancerCardiovascular DiseasesLung Diseases+6 more
Population Health Research Institute200,000 enrolled34 locationsNCT03225586